Utah Medical Products, Inc.UTMDNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+125.8%
5Y CAGR+332.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+125.8%/yr
vs +2.7%/yr prior
5Y CAGR
+332.9%/yr
Recent deceleration
Acceleration
+123.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1521.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 40.20% |
| 2024 | -56.17% |
| 2023 | 6.61% |
| 2022 | 3.49% |
| 2021 | 1.38% |
| 2020 | 0.03% |
| 2019 | 58.64% |
| 2018 | 3.14% |
| 2017 | -1.29% |
| 2016 | -12.28% |